demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderateCOVID-19 severe or critically
COVID 19 hospitalizedCOVID-19 mild to moderateCOVID-19 severe or critically
azithromycin RECOVERY ... Sekhavati COALITION I Covid-19 Brazil ... Rashad A ... COALITION II Covid-19 Brazil ...

4 studies excluded by filtering options 0

5259 Duke University azithromycin, 2020 210excludedrisk of bias not avaialble
5365 Rosenberg, 2020 1133not a RCThigh risk of bias
6332 Rodriguez-Molinero, 2020 1100not a RCTrisk of bias not avaialble
6381 Espitia-Hernandez, 2020 1310not a RCTrisk of bias not avaialble